Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E K Bergsland

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Seminars in Oncology|October 31, 2001
Molecular mechanisms underlying the development of hepatocellular carcinomaE K Bergsland
Current Opinion in Oncology|July 11, 2000
Hepatocellular carcinomaE K Bergsland, A P Venook
European Heart Journal. Cardiovascular Imaging|May 25, 2015
Transcatheter pulmonic valve replacement in carcinoid heart diseaseB Heidecker, P Moore, E K Bergsland, et al.
British Journal of Cancer|July 7, 2005
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancerA H Ko, J Hwang, A P Venook, et al.
Endocrine-Related Cancer|April 16, 2016
A phase II study of axitinib in advanced neuroendocrine tumorsJ R Strosberg, M Cives, J Hwang, et al.
Oncogene|April 2, 2013
Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitorsG S Ducker, C E Atreya, J P Simko, et al.
British Journal of Cancer|September 12, 2013
A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancerR K Kelley, J Hwang, M J M Magbanua, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2013
Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlatesR K Kelley, H S Nimeiri, P N Munster, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Seminars in Oncology|October 31, 2001
Molecular mechanisms underlying the development of hepatocellular carcinomaE K Bergsland
Current Opinion in Oncology|July 11, 2000
Hepatocellular carcinomaE K Bergsland, A P Venook
European Heart Journal. Cardiovascular Imaging|May 25, 2015
Transcatheter pulmonic valve replacement in carcinoid heart diseaseB Heidecker, P Moore, E K Bergsland, et al.
British Journal of Cancer|July 7, 2005
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancerA H Ko, J Hwang, A P Venook, et al.
Endocrine-Related Cancer|April 16, 2016
A phase II study of axitinib in advanced neuroendocrine tumorsJ R Strosberg, M Cives, J Hwang, et al.
Oncogene|April 2, 2013
Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitorsG S Ducker, C E Atreya, J P Simko, et al.
British Journal of Cancer|September 12, 2013
A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancerR K Kelley, J Hwang, M J M Magbanua, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2013
Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlatesR K Kelley, H S Nimeiri, P N Munster, et al.
Pageof 1